Ents We would like to thank the staff at the Curakliniken in

De EmBreveAqui
Ir para: navegação, pesquisa

Wald A, Van Thiel DH, Hoechstetter L, Gavaler JS, Egler KM, Verm R, Scott L, Lester R: Ust be performed in the standard position and inNovaes et al. Gastrointestinal transit: the effect in the menstrual cycle. Scand J Gastroenterol 2012, 47:1165?173. Ohlsson B, Sjoberg K, Alm R, Fredrikson GN: Patients with irritable bowel syndrome and dysmotility express antibodies against gonadotropinreleasing hormone in serum. Neurogastroenterol Motil 2011, 23:1000?006. Mathias JR, Clench MH, Abell TL, Koch KL, Lehman G, Robinson M, Rothstein R, Snape WJ: Effect of leuprolide acetate in remedy of abdominal discomfort and nausea in premenopausal ladies with functional bowel disease: a double-blind, placebo-controlled, randomized study. Dig Dis Sci 1998, 43:1347?355. Palomba S, Orio F Jr, Manguso F, Russo T, Falbo A, Lombardi G, Doldo P, Zullo F: Leuprolide acetate remedy with and with out coadministration of tibolone in premenopausal females with menstrual cycle-related irritable bowel syndrome. Fertil Steril 2005, 83:1012?020. Ohlsson B, Veress B, Janciauskiene S, Montgomery A, Haglund M, Wallmark A: Chronic intestinal pseudo-obstruction because of buserelin-induced formation of anti-GnRH antibodies. Gastroenterology 2007, 132:45?1. Sand E, Voss U, Hammar O, Alm R, Nordin Fredrikson G, Ohlsson B, Ekblad E: Gonadotropin-releasing hormone analog buserelin causes neuronal loss i.Ents We choose to thank the employees in the Curakliniken in Malm?and the Internal Medicine Research Group, Sk e University Hospital, Malm? for skilful inclusion and collection of blood samples and questionnaires in individuals and controls. This study was sponsored by the Foundation of Region Sk e, Lundstr Foundation, Crafoord Foundation, Bengt Ihre Foundation and Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse. Author specifics 1 Division of Clinical Sciences, Division of Internal Medicine, Sk e University Hospital, Lund University, 205 02, Malm? Sweden. 2Faculty of Well being and Society, Institution of Care Science, Malm?University, Malm? Sweden. 3Department of Clinical Sciences, Division of Rheumatology, Sk e University Hospital, Lund University, 205 02, Malm? Sweden. Received: 14 June 2013 Accepted: 31 October PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/29069523 2013 Published: five November 2013 References 1. Quigley EM, Bytzer P, Jones R, Mearin F: Irritable bowel syndrome: the burden and unmet needs in Europe. Dig Liver Dis 2006, 38:717?23. 2. Wald A, Van Thiel DH, Hoechstetter L, Gavaler JS, Egler KM, Verm R, Scott L, Lester R: Gastrointestinal transit: the effect on the menstrual cycle. Gastroenterology 1981, 80:1497?500. three. Gonenne J, Esfandyari T, Camilleri M, Burton DD, Stephens DA, Baxter KL, Zinsmeister AR, Bharucha AE: Effect of female PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/27797473 sex hormone supplementation and withdrawal on gastrointestinal and colonic transit in postmenopausal girls. Neurogastroenterol Motil 2006, 18:911?18.Hammar et al. BMC Pregnancy and Childbirth 2013, 13:201 http://www.biomedcentral.com/1471-2393/13/Page 9 of4. 5.six. 16.17. 18. 19.20. 21. PM, Crowley WF Jr: Gonadotropin-releasing hormone and its analogs. Annu Rev Med 1994, 45:391?05. Huang W, Yao B, Sun L, Pu R, Wang L, Zhang R: Immunohistochemical and in situ hybridization research of gonadotropin releasing hormone (GnRH) and its receptor in rat digestive tract. Life Sci 2001, 68:1727?734.